Home Newsfeeds Stifel Maintains Buy on Adobe, Lowers Price Target to $375

Stifel Maintains Buy on Adobe, Lowers Price Target to $375

Stifel analyst Parker Lane maintains Adobe (NASDAQ:ADBE) with a Buy and lowers the price target from $500 to $375.

byBenzinga Newsdesk

September 16, 2022

1 minute read

Stifel analyst Parker Lane maintains Adobe (NASDAQ:ADBE) with a Buy and lowers the price target from $500 to $375.

Watching Archer Aviation, Inc; Grizzly Research Out With Short Report On Co Titled “We Believe Archer Aviation, Inc (NASDAQ:ACHR) Is A Lame Duck”

By Happy Mohamed

August 16, 8:59 AM

https://grizzlyreports.com/we-believe-archer-aviation-inc-nasdaqachr-is-a-lame-duck/ Scarce Flight Activity; Recycled Video material; Misleading DoD Contract; Partners bought with cheap Warrants Archer

ACHR

Analyst Ratings

What 4 Analyst Ratings Have To Say About Box

By Benzinga Insights

December 12, 5:01 PM

Analysts have provided the following ratings for Box (NYSE:BOX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

BOX

Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here’s What They’re Thinking

By Lara Goldstein

August 3, 3:03 PM

Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon

KAYS

STRATA Announces JCAD Publication: Photopneumatic Technology For The Treatment Of Mild-To-Moderate Acne Vulgaris

By Happy Mohamed

July 11, 8:34 AM

STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced

SSKN

Stifel Maintains Buy on Adobe, Lowers Price Target to $375

Related Posts

Watching Archer Aviation, Inc; Grizzly Research Out With Short Report On Co Titled “We Believe Archer Aviation, Inc (NASDAQ:ACHR) Is A Lame Duck”

What 4 Analyst Ratings Have To Say About Box

Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here’s What They’re Thinking

STRATA Announces JCAD Publication: Photopneumatic Technology For The Treatment Of Mild-To-Moderate Acne Vulgaris